Oritavancin Nucleus Factor D - Request Quote
Oritavancin Nucleus Factor D
| SZ CAT No: | SZ-O026005 |
| CAS No | NA |
| Mol.F. | C75H90Cl2N10O28 |
| Mol.Wt. | 1650.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Oritavancin Nucleus Factor D is chemically Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabinohexopyranosyl)-N3''-carboxymethyl-19-dechloro-, (4''R)- (9CI). Oritavancin Nucleus Factor D is supplied with detailed characterization data compliant with regulatory guideline. Oritavancin Nucleus Factor D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oritavancin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Oritavancin Nucleus Factor D
Purchase Oritavancin Nucleus Factor D
Oritavancin Nucleus Factor D suppliers
Oritavancin Nucleus Factor D manufacturers
Oritavancin Nucleus Factor D price
Order Oritavancin Nucleus Factor D
Enquire Oritavancin Nucleus Factor D
Oritavancin Nucleus Factor D cost
Oritavancin Nucleus Factor D Supplier
Oritavancin Nucleus Factor D Distributor
Oritavancin Nucleus Factor D for Method Validation
Oritavancin Reference Standard
Oritavancin Nucleus Factor D for ANDA Filing
Oritavancin Nucleus Factor D for Forced Degradation Studies
Oritavancin Nucleus Factor D Identification Standards
Oritavancin Nucleus Factor D for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


